Blogging Organization Outsource Development San Diego 
Xconomy
APRIL 3, 2019
Contract research organization Charles River Labs is shutting down its San Diego-area operations, moving the work done there to one of its two Northern California sites. Charles River says it was involved with about 85 percent of the drugs. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.
Xconomy
AUGUST 7, 2019
Organovo says it has run out of money to advance its efforts to develop 3-D “patches” of living human liver tissue to tide over people waiting for an organ transplant. In the meantime, the company built a business as a contract research organization around its 3-D human tissue cultures, which pharma companies have used.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Xconomy
AUGUST 9, 2016
When Xconomy convened a dinner discussion earlier this year that included prominent San Diego cybersecurity innovators, startup founders, and system administrators, I was stunned to learn that Gary Hayslip oversees an IT network that blocks an average of 800,000 cyber attacks a day. Gary Hayslip.
Xconomy
NOVEMBER 6, 2017
The San Diego company, founded a decade ago on 3D bio-printing technology developed by the University of Missouri’s Gabor Forgacs, appeared to be gaining momentum on multiple fronts. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.
Xconomy
OCTOBER 5, 2016
San Diego-based Organovo (NASDAQ: ONVO ) said today it plans to use its 3D bio-printing technology to produce living human liver tissue “patches” that can be transplanted in patients with fatal liver disease. liver transplant waiting list. liver transplant waiting list.
Xconomy
OCTOBER 24, 2016
A San Diego civil engineer who has developed an alternative technology for automating the measurement of water flow gave the best presentation at EvoNexus Fall Demo Day, an event that drew nearly 400 entrepreneurs, investors, and supporters late Thursday to Qualcomm’s corporate headquarters. was founded as Catalyst eClinical.).
Xconomy
SEPTEMBER 9, 2016
Since then, the San Diego company has built a thriving business as a contract research organization (CRO) that tests experimental drug compounds on bio-printed liver tissue. We look at ourselves as a human tissues company…We’ll test your compound in our lab as a service.”. Now Organovo is expanding its capabilities.
Expert insights. Personalized for you.
59 
Let's personalize your content